Hepatitis C comorbidities affecting the course and response to therapy

doi:10.3748/wjg.15.4993

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2785)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

441

HTML

2178

Figures (1-4)

166

Sum=2785

Oct 28, 2009 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Oct 28, 2009; 15(40): 4993-4999
Published online Oct 28, 2009. doi: 10.3748/wjg.15.4993

Full Size Figure Download Figure

Figure 2 HCV-induced insulin resistance[21-23]. SOC-3: Suppressor of cytokine-3; PPAR: Peroxisome proliferators activated receptor; HSCs: Hepatic stellate cells.

Citation: El-Zayadi AR. Hepatitis C comorbidities affecting the course and response to therapy. World J Gastroenterol 2009; 15(40): 4993-4999
URL: https://www.wjgnet.com/1007-9327/full/v15/i40/4993.htm
DOI: https://dx.doi.org/10.3748/wjg.15.4993